Abstract
Cardiac transient receptor potential canonical (TRPC) channels are crucial upstream components of Ca(2+)/calcineurin/nuclear factor of activated T cells (NFAT) signaling, thereby controlling cardiac transcriptional programs. The linkage between TRPC-mediated Ca(2+) signals and NFAT activity is still incompletely understood. TRPC conductances may govern calcineurin activity and NFAT translocation by supplying Ca(2+) either directly through the TRPC pore into a regulatory microdomain or indirectly via promotion of voltage-dependent Ca(2+) entry. Here, we show that a point mutation in the TRPC3 selectivity filter (E630Q), which disrupts Ca(2+) permeability but preserves monovalent permeation, abrogates agonist-induced NFAT signaling in HEK293 cells as well as in murine HL-1 atrial myocytes. The E630Q mutation fully retains the ability to convert phospholipase C-linked stimuli into L-type (Ca(V)1.2) channel-mediated Ca(2+) entry in HL-1 cells, thereby generating a dihydropyridine-sensitive Ca(2+) signal that is isolated from the NFAT pathway. Prevention of PKC-dependent modulation of TRPC3 by either inhibition of cellular kinase activity or mutation of a critical phosphorylation site in TRPC3 (T573A), which disrupts targeting of calcineurin into the channel complex, converts cardiac TRPC3-mediated Ca(2+) signaling into a transcriptionally silent mode. Thus, we demonstrate a dichotomy of TRPC-mediated Ca(2+) signaling in the heart constituting two distinct pathways that are differentially linked to gene transcription. Coupling of TRPC3 activity to NFAT translocation requires microdomain Ca(2+) signaling by PKC-modified TRPC3 complexes. Our results identify TRPC3 as a pivotal signaling gateway in Ca(2+)-dependent control of cardiac gene expression.
| Original language | English |
|---|---|
| Pages (from-to) | 10556-10561 |
| Number of pages | 6 |
| Journal | Proceedings of the National Academy of Sciences of the United States of America (PNAS) |
| Volume | 108 |
| Issue number | 26 |
| DOIs | |
| Publication status | Published - 28 Jun 2011 |
Fields of science
- 103036 Theoretical physics
- 211904 Biomechanics
- 103020 Surface physics
- 210 Nanotechnology
- 104010 Macromolecular chemistry
- 106006 Biophysics
- 106022 Microbiology
- 106048 Animal physiology
- 209 Industrial Biotechnology
- 304 Medical Biotechnology
- 404 Agricultural Biotechnology, Food Biotechnology
- 106049 Ultrastructure research
- 103021 Optics
- 106002 Biochemistry
- 104017 Physical chemistry
- 208 Environmental Biotechnology
- 104014 Surface chemistry
- 106023 Molecular biology
- 107 Other Natural Sciences
- 301110 Physiology
- 301206 Pharmacology
- 206 Medical Engineering
- 301306 Medical molecular biology
- 302044 Medical physics
- 301902 Immunology
- 305910 Traffic medicine
JKU Focus areas
- Engineering and Natural Sciences (in general)